Doctoral Dissertations

Orcid ID

https://orcid.org/0000-0001-6836-6031

Date of Award

5-2024

Degree Type

Dissertation

Degree Name

Doctor of Philosophy

Major

Biochemistry and Cellular and Molecular Biology

Major Professor

Rajan Lamichhane

Committee Members

Rajan Lamichhane, Francisco Barrera, Gladys Alexandre, Barry Bruce, Jaan Mannik

Abstract

G protein-coupled receptors (GPCRs) are one of the largest transmembrane receptor families. The wide expression and diverse signal transduction functions make them an ideal target for characteristic drug design. The A2A adenosine receptor (A2AAR), a representative of class A GPCRs, has been extensively used to reveal the structural information of class A GPCRs. As a purinergic receptor, A2AAR is activated by adenosine in the human body, triggering cyclic adenosine monophosphate (cAMP) and immunosuppression pathways. A2AARs are highly expressed in the brain and are crucial in regulating glutamate and dopamine release. As a result, the A2AAR became a potential therapeutic target for treating neurodegenerative diseases. In recent years, A2AARs have been identified in specific cardiac cells where they regulate myocardial oxygen consumption and coronary blood flow. Accordingly, the A2AAR-targeted drug design and optimization has become increasingly valued. However, the dynamic nature of A2AAR structures poses challenges in drug design. Therefore, the study of structural dynamics provides valuable information for ligand identification and drug prediction. In this work, we used total internal reflection fluorescence (TIRF) imaging to visualize the real-time dynamics of ligand binding and activation of the A2AAR at the molecular level. We observed reversible and sequential dynamic behaviors in A2AAR transmembrane helix VII (TM VII). Furthermore, the constitutively activating mutations (CAMs) didn’t show the ligand-specific conformational dynamics like the wild type A2AAR, but CAMs and the Mini-Gs shifted conformational equilibrium towards the intermediate state, while D52N, a constitutively inactivating mutation, had the opposite effect. We also successfully stabilized the A2AARs in native membrane environment and incorporated them into nanodiscs using the polymers styrene maleic acid (SMA) and di-isobutylene maleic acid (DIBMA). This allowed us to observe more transition events between active-like conformational states between transmembrane helices IV and VI upon agonist and Mini-GS binding. Overall, this work has filled the gap in understanding A2AAR structural dynamics at the single-molecule level, emphasizing the significance of intermediate states in A2AAR dynamics and paving the way for future A2AAR-targeted drug design strategies.

Download
Files over 3MB may be slow to open. For best results, right-click and select "save as..."

Share

COinS